BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3160967)

  • 1. Potentiation of motoneurone excitability by combined administration of 5-HT agonist and TRH analogue.
    Clarke KA; Parker AJ; Stirk GC
    Neuropeptides; 1985 Jun; 6(3):269-82. PubMed ID: 3160967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motoneurone excitability during antidromically evoked inhibition after administration of a thyrotrophin releasing hormone (TRH) analogue.
    Clarke KA; Parker AJ; Stirk GC
    Neuropeptides; 1984 Sep; 4(5):403-11. PubMed ID: 6436727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motoneurone excitability after administration of a thyrotrophin releasing hormone analogue.
    Clarke KA; Stirk G
    Br J Pharmacol; 1983 Nov; 80(3):561-5. PubMed ID: 6416344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and chronic effects of intrathecal galanin on behavioural and biochemical markers of spinal motor function in adult rats.
    Fone KC; Dixon DM
    Brain Res; 1991 Mar; 544(1):118-25. PubMed ID: 1713112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the effects of serotonin, substance P and thyrotropin-releasing hormone on excitability of rat spinal motoneurons in vivo.
    White SR
    Brain Res; 1985 May; 335(1):63-70. PubMed ID: 2408702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-CT or DOI augments TRH analog-induced gastric acid secretion at the dorsal vagal complex.
    Varanasi S; Chi J; Stephens RL
    Am J Physiol; 1997 Nov; 273(5):R1607-11. PubMed ID: 9374800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of 5-HT2 receptors in the behaviours produced by intrathecal administration of selected 5-HT agonists and the TRH analogue (CG 3509) to rats.
    Fone KC; Johnson JV; Bennett GW; Marsden CA
    Br J Pharmacol; 1989 Mar; 96(3):599-608. PubMed ID: 2470455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional interactions between TRH and 5-hydroxytryptamine (5-HT) and proctolin in rat brain and spinal cord.
    Marsden CA; Bennett GW; Fone KC; Johnson JV
    Ann N Y Acad Sci; 1989; 553():121-34. PubMed ID: 2566294
    [No Abstract]   [Full Text] [Related]  

  • 9. Serotonin and co-localized peptides: effects on spinal motoneuron excitability.
    White SR
    Peptides; 1985; 6 Suppl 2():123-7. PubMed ID: 2417208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin enhances gastric acid response to TRH analogue in dorsal vagal complex through 5-HT2 receptors in rats.
    Yoneda M; Taché Y
    Am J Physiol; 1995 Jul; 269(1 Pt 2):R1-6. PubMed ID: 7631881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intrathecal proctolin administration on the behaviour evoked by the thyrotrophin-releasing hormone (TRH) analogue (RX 77368) and the indoleamine, TRH, substance P and calcitonin gene-related peptide levels and choline acetyltransferase activity in the rat spinal cord.
    Fone KC; Johnson JV; Bennett GW; Marsden CA
    Brain Res; 1988 Sep; 460(1):22-8. PubMed ID: 2464406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRH analogue affects information transfer through the ventrobasal thalamus.
    Clarke KA
    Neuropeptides; 1986 Jan; 7(1):31-9. PubMed ID: 3081829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of repeated administration of a long acting TRH analogue (RX77368), on TSH, T4, T3 and prolactin in patients with motor neuron disease.
    Eckland DJ; Modarres-Sadeghi H; Lightman SL; Guiloff RJ
    J Neurol Neurosurg Psychiatry; 1990 Sep; 53(9):803-4. PubMed ID: 2123237
    [No Abstract]   [Full Text] [Related]  

  • 14. Thyrotropin-releasing hormone analogue and serotonin interact within the dorsal vagal complex to augment gastric acid secretion.
    McTigue DM; Rogers RC; Stephens RL
    Neurosci Lett; 1992 Sep; 144(1-2):61-4. PubMed ID: 1436715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action of 5-hydroxytryptamine, substance P, thyrotropin-releasing hormone and clonidine on motoneurone excitability.
    Bédard PJ; Tremblay LE; Barbeau H; Filion M; Maheux R; Richards CL; DiPaolo T
    Can J Neurol Sci; 1987 Aug; 14(3 Suppl):506-9. PubMed ID: 2445457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyrotropin releasing hormone (TRH) and a degradation stabilized analogue (RX77368) stimulate phosphoinositide turnover in cultured astrocytes in a regionally specific manner.
    McDermott AM; Dickinson SL; Wilkin GP
    Neurochem Int; 1992 Apr; 20(3):307-13. PubMed ID: 1338971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiological observations in patients with motor neuron disease receiving a thyrotropin releasing hormone analogue (RX77368).
    Guiloff RJ; Stålberg E; Eckland DJ; Lightman SL
    J Neurol Neurosurg Psychiatry; 1987 Dec; 50(12):1633-40. PubMed ID: 3125307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative behavioural and biochemical effects of repeated intrathecal administration of thyrotrophin-releasing hormone (TRH) or two analogues of TRH in adult rats.
    Fone KC; Johnson JV; Marsden CA; Bennett GW
    Neuropharmacology; 1989 Aug; 28(8):867-75. PubMed ID: 2476681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin and thyrotropin-releasing hormone do not augment their effects on gastric motility on their microinjection into the nucleus raphe obscurus of the rat.
    Krowicki ZK; Hornby PJ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):499-508. PubMed ID: 7714805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The spinal reflex of chronic spinal rats is supersensitive to 5-HTP but not to TRH or 5-HT agonists.
    Nagano N; Ono H; Ozawa M; Fukuda H
    Eur J Pharmacol; 1988 May; 149(3):337-44. PubMed ID: 3137080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.